Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody) - Concepedia

Concepedia

Publication | Closed Access

Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody)

59

Citations

21

References

2007

Year

Claes Karlsson, Lotta Hansson, Fredrik Celsing, Jeanette Lundin

Hematological MalignancyLymphoid NeoplasiaAutoimmune DiseaseHematologyImmunologyAutoimmunityImmunotherapyMedicineCd52 Monoclonal AntibodyAplastic Anemia

References

	Year	Citations

Page 1